Taxes - Schedule of Reconciled to the Income Before Income Taxes (Details) - USD ($) |
6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Apr. 30, 2026 |
Apr. 30, 2025 |
Oct. 31, 2025 |
Oct. 31, 2024 |
Oct. 31, 2023 |
|
| Schedule of Reconciled to the Income Before Income Taxes [Abstract] | |||||
| Income before income tax provision | $ 564,087 | $ 174,800 | $ 85,556 | $ 2,149,669 | |
| PRC statutory tax rate | 25.00% | 25.00% | 25.00% | 25.00% | |
| Income tax computed at PRC statutory tax rate | $ 141,022 | $ 43,700 | $ 21,389 | $ 537,417 | |
| Preferential tax treatments | (176,122) | (47,547) | 71,304 | (244,284) | |
| Non-deductible expense | 188 | 3,781 | 2,423 | 2,775 | |
| Additional deduction for research and development expenses | (9,289) | (34,277) | (26,077) | ||
| Tax-exempted income | (1,129) | (304) | 6,595 | (828) | |
| Tax effect of unused tax losses not recognised | 1,489 | ||||
| Total | $ (43,841) | $ (370) | $ 67,434 | $ 269,003 | $ 307,441 |
| X | ||||||||||
- Definition Tax effect of unused tax losses not recognised No definition available.
|
| X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense). No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to domestic income tax settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|